Jan Komtebedde
Technik-/Wissenschafts-/F&E-Leiter bei Corvia Medical, Inc.
Profil
Jan Komtebedde is currently the Chief Medical Officer & Senior Vice President at Corvia Medical, Inc. He previously worked as the Director-Structural Heart Business Unit at Abbott Laboratories, Director-Clinical Research & Development at Heartport, Inc., Chief Medical Officer & Executive Vice President at Ancora Heart, Inc., Vice President-Marketing & Business Development at Evalve, Inc., and as a Faculty Member at UC Davis School of Medicine.
He holds a doctorate degree from the University of Utrecht.
Aktive Positionen von Jan Komtebedde
Unternehmen | Position | Beginn |
---|---|---|
Corvia Medical, Inc.
Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Jan Komtebedde
Unternehmen | Position | Ende |
---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Ancora Heart, Inc.
Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
UC Davis School of Medicine | Corporate Officer/Principal | - |
Evalve, Inc.
Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Vertrieb & Marketing | - |
Ausbildung von Jan Komtebedde
University of Utrecht | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private Unternehmen | 4 |
---|---|
Evalve, Inc.
Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Health Technology |
Corvia Medical, Inc.
Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Health Technology |
Ancora Heart, Inc.
Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Finance |